Brad Sigmon will be put to death March 7 It will be the first time a firing squad is used in 15 years Some say a firing squad may be more humane than lethal injections Sigmon chose a firing squad over ...

A charity dedicated to helping people living with the biggest cause of sight loss, is to host a series of information events in Wrexham.

The current state of treatment for geographic atrophy is marked by two approved therapies that slow GA progression: ...

Medically reviewed by Danielle Weiss, MD Diabetic macular edema (DME) is a leading cause of vision loss in people with ...

LUXTURNA has significant market potential due to the high unmet need for effective treatments in rare genetic conditions. With its FDA approval for specific mutations in the RPE65 gene, it offers ...

DelveInsight's "LUXTURNA Market Size, Forecast, and Market Insight Report" highlights the details around LUXTURNA, a one-time ...

Administered via intravitreal injection, Synthopsin-MCO-010 possesses a promoter to specifically target ON-bipolar cells.

Vision loss is a growing concern in India, especially macular degeneration - a common eye condition. Once known to be ...

Unity Biotechnology has reported outcomes from its randomised Phase IIb ASPIRE study of intravitreal UBX1325 for diabetic ...

Although scientists said larger clinical trials will be needed, the early results point to a 50-50 chance that this treatment ...

UNITY anticipates the complete 36-week data results of the remaining patients in the second quarter of 2025.